JCB logo
Avanti Polar Lipids
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 5 May 2003. doi:10.1083/jcb1613rr5
This Article
Right arrow Full Text (PDF, 816K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tuma, R. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2003/5/457-b $5.00
The Journal of Cell Biology, Volume 161, Number 3, 457-b-457


Research Roundup

Crm1 locks up replication factors


Crm1 in the cell cycle.

Yamaguchi/Elsevier

Limiting replication to a single round per division is critical for cells, but the proteins that control the process in metazoans have remained obscure. Now, Ryuji Yamaguchi and John Newport (University of California, San Diego, CA) find that Crm1 sequesters MCM helicase in the nucleus, preventing it from binding to the chromatin where it would initiate a new round of DNA synthesis.

Working in Xenopus egg extracts, the team found that, although the prevention of rereplication is dependent on high concentrations of Ran-GTP and Cdk2 kinase activity, it does not require nuclear export of MCM. That means that Crm1 may have a new mechanism of action, since all of its previously known functions involved nuclear transport.

"We think this makes sense," says Newport, "because it is an extremely rapid mechanism for inactivating MCM." If the repression required transporting MCM out of the nucleus, the process would be considerably slower and more mistakes would occur in a process that can't tolerate errors.

The target of Cdk2 in the system is not yet clear, but the group thinks it may be MCM itself. Given the observation that the inhibition requires Ran-GTP, a protein known to stabilize interactions between Crm1 and its target proteins, the authors hypothesize that Crm1, the phosphorylated MCM protein, and Ran-GTP form a heterotrimeric complex. But, says Newport, this is still a work in progress and it will take more experiments to unveil just how Crm1 blocks MCM activity. {blacksquare}

Reference:

Yamaguchi, R., et al. 2003. Cell. 113:115–125.[CrossRef][Medline]



Rabiya S. Tuma

rabiya{at}nasw.org


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



This Article
Right arrow Full Text (PDF, 816K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuma, R. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tuma, R. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents